
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glucocerebrosidase mutations and Parkinson disease
Sophia R.L. Vieira, Anthony H.V. Schapira
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1105-1117
Open Access | Times Cited: 39
Sophia R.L. Vieira, Anthony H.V. Schapira
Journal of Neural Transmission (2022) Vol. 129, Iss. 9, pp. 1105-1117
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Role of GBA variants in Lewy body disease neuropathology
Ronald L. Walton, Shunsuke Koga, Alexandra Beasley, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Closed Access | Times Cited: 9
Ronald L. Walton, Shunsuke Koga, Alexandra Beasley, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Closed Access | Times Cited: 9
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson’s disease
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Xuxiang Zhang, Heng Wu, Beisha Tang, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Challenges in Gaucher disease: Perspectives from an expert panel
Gregory A. Grabowski, Priya S. Kishnani, Roy N. Alcalay, et al.
Molecular Genetics and Metabolism (2025), pp. 109074-109074
Closed Access | Times Cited: 1
Gregory A. Grabowski, Priya S. Kishnani, Roy N. Alcalay, et al.
Molecular Genetics and Metabolism (2025), pp. 109074-109074
Closed Access | Times Cited: 1
The Consequences of GBA Deficiency in the Autophagy–Lysosome System in Parkinson’s Disease Associated with GBA
Eddie Pradas, Marta Martínez‐Vicente
Cells (2023) Vol. 12, Iss. 1, pp. 191-191
Open Access | Times Cited: 20
Eddie Pradas, Marta Martínez‐Vicente
Cells (2023) Vol. 12, Iss. 1, pp. 191-191
Open Access | Times Cited: 20
The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson’s Disease: a New Genetic State of the Art
Júlio César Claudino dos Santos, Gabriela Braga Cabrera Mano, André Rodrigues da Cunha Barreto Vianna, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6754-6770
Closed Access | Times Cited: 7
Júlio César Claudino dos Santos, Gabriela Braga Cabrera Mano, André Rodrigues da Cunha Barreto Vianna, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 9, pp. 6754-6770
Closed Access | Times Cited: 7
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson’s disease
Cheryl E. G. Leyns, Alice Prigent, Brenna Beezhold, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Cheryl E. G. Leyns, Alice Prigent, Brenna Beezhold, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Genetics of Parkinson’s Disease: state-of-the-art and role in clinical settings
Jarosław Dulski, Owen A. Ross, Zbigniew K. Wszołek
Neurologia i Neurochirurgia Polska (2024) Vol. 58, Iss. 1, pp. 38-46
Open Access | Times Cited: 5
Jarosław Dulski, Owen A. Ross, Zbigniew K. Wszołek
Neurologia i Neurochirurgia Polska (2024) Vol. 58, Iss. 1, pp. 38-46
Open Access | Times Cited: 5
The lysosomal β-glucocerebrosidase strikes mitochondria: implications for Parkinson’s therapeutics
Juan Carlos Rubilar, Tiago F. Outeiro, Andrés D. Klein
Brain (2024) Vol. 147, Iss. 8, pp. 2610-2620
Closed Access | Times Cited: 5
Juan Carlos Rubilar, Tiago F. Outeiro, Andrés D. Klein
Brain (2024) Vol. 147, Iss. 8, pp. 2610-2620
Closed Access | Times Cited: 5
Neuronopathic GBA1L444P Mutation Accelerates Glucosylsphingosine Levels and Formation of Hippocampal Alpha-Synuclein Inclusions
Casey L. Mahoney-Crane, Megha Viswanathan, Drèson L. Russell, et al.
Journal of Neuroscience (2022) Vol. 43, Iss. 3, pp. 501-521
Open Access | Times Cited: 21
Casey L. Mahoney-Crane, Megha Viswanathan, Drèson L. Russell, et al.
Journal of Neuroscience (2022) Vol. 43, Iss. 3, pp. 501-521
Open Access | Times Cited: 21
Genetic Evidence for Endolysosomal Dysfunction in Parkinson’s Disease: A Critical Overview
Vidal Yahya, Alessio Di Fonzo, Edoardo Monfrini
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6338-6338
Open Access | Times Cited: 12
Vidal Yahya, Alessio Di Fonzo, Edoardo Monfrini
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6338-6338
Open Access | Times Cited: 12
Marine-Derived Components: Can They Be a Potential Therapeutic Approach to Parkinson’s Disease?
Joana Silva, Celso Alves, Francisca Soledade, et al.
Marine Drugs (2023) Vol. 21, Iss. 8, pp. 451-451
Open Access | Times Cited: 11
Joana Silva, Celso Alves, Francisca Soledade, et al.
Marine Drugs (2023) Vol. 21, Iss. 8, pp. 451-451
Open Access | Times Cited: 11
Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study
Sinthuja Pachchek, Zied Landoulsi, Lukas Pavelka, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Sinthuja Pachchek, Zied Landoulsi, Lukas Pavelka, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Electric-field induced sleep promotion and lifespan extension in Gaucher's disease model flies
Takaki Nedachi, Haruhisa Kawasaki, Eiji Inoue, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101915-101915
Closed Access
Takaki Nedachi, Haruhisa Kawasaki, Eiji Inoue, et al.
Biochemistry and Biophysics Reports (2025) Vol. 41, pp. 101915-101915
Closed Access
Early-onset Parkinson's disease in a patient with a rare homozygous pathogenic GBA1 variant and no Gaucher disease symptoms
Juliana Cordovil Cotrin, Rafael Mina Piergiorge, Andressa Pereira Gonçalves, et al.
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access
Juliana Cordovil Cotrin, Rafael Mina Piergiorge, Andressa Pereira Gonçalves, et al.
Neurogenetics (2025) Vol. 26, Iss. 1
Closed Access
Perspective Chapter: Next-Generation Sequencing and Variant Cataloging for Screening and Diagnosis of Sphingolipidoses and Mucopolysaccharidoses
Irina Vlasova-St. Louis, Uri Barak, Svetlana F. Khaiboullina
IntechOpen eBooks (2025)
Closed Access
Irina Vlasova-St. Louis, Uri Barak, Svetlana F. Khaiboullina
IntechOpen eBooks (2025)
Closed Access
Activation and Purification of ß‐Glucocerebrosidase by Exploiting its Transporter LIMP‐2 – Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease
Jan Philipp Dobert, Simon Bub, Rebecca Mächtel, et al.
Advanced Science (2024) Vol. 11, Iss. 25
Open Access | Times Cited: 3
Jan Philipp Dobert, Simon Bub, Rebecca Mächtel, et al.
Advanced Science (2024) Vol. 11, Iss. 25
Open Access | Times Cited: 3
A Fixable Fluorescence‐Quenched Substrate for Quantitation of Lysosomal Glucocerebrosidase Activity in Both Live and Fixed Cells
Sha Zhu, Matthew C. Deen, Yanping Zhu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 40
Open Access | Times Cited: 8
Sha Zhu, Matthew C. Deen, Yanping Zhu, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 40
Open Access | Times Cited: 8
Soluble mannose receptor: A potential biomarker in Gaucher disease
Brendan Beaton, Derralynn Hughes
European Journal Of Haematology (2024) Vol. 112, Iss. 5, pp. 794-801
Open Access | Times Cited: 2
Brendan Beaton, Derralynn Hughes
European Journal Of Haematology (2024) Vol. 112, Iss. 5, pp. 794-801
Open Access | Times Cited: 2
Iron Dyshomeostasis in Neurodegeneration with Brain Iron Accumulation (NBIA): Is It the Cause or the Effect?
Francesco Agostini, Bibiana Sgalletta, Marco Bisaglia
Cells (2024) Vol. 13, Iss. 16, pp. 1376-1376
Open Access | Times Cited: 2
Francesco Agostini, Bibiana Sgalletta, Marco Bisaglia
Cells (2024) Vol. 13, Iss. 16, pp. 1376-1376
Open Access | Times Cited: 2
Comprehensive Analysis and Experimental Validation of the Parkinson’s Disease Lysosomal Gene ACP2 and Pan-cancer
Liang Yu, Guangshang Zhong, Yangyang Li, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 2
Liang Yu, Guangshang Zhong, Yangyang Li, et al.
Biochemical Genetics (2024)
Closed Access | Times Cited: 2
Genetic Architecture of Parkinson’s Disease
М. И. Шадрина, P. A. Slominsky
Biochemistry (Moscow) (2023) Vol. 88, Iss. 3, pp. 417-433
Open Access | Times Cited: 5
М. И. Шадрина, P. A. Slominsky
Biochemistry (Moscow) (2023) Vol. 88, Iss. 3, pp. 417-433
Open Access | Times Cited: 5
The international cooperative Gaucher group (ICCG) Gaucher registry
Neal J. Weinreb
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 4, pp. 101522-101522
Closed Access | Times Cited: 5
Neal J. Weinreb
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 4, pp. 101522-101522
Closed Access | Times Cited: 5
Genetics of Multiple System Atrophy and Progressive Supranuclear Palsy: A Systemized Review of the Literature
Anastasia Bougea
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5281-5281
Open Access | Times Cited: 4
Anastasia Bougea
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5281-5281
Open Access | Times Cited: 4
Mitochondrial oxidant stress promotes α-synuclein aggregation and spreading in mice with mutated glucocerebrosidase
Pietro La Vitola, Éva M. Szegő, Rita Pinto‐Costa, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Pietro La Vitola, Éva M. Szegő, Rita Pinto‐Costa, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The RAB32 p.Ser71Arg Variant in Parkinsonisms: Insights from a Large Italian Cohort
Luca Magistrelli, Marta Benedetta Brumana, Valeria Rimoldi, et al.
Movement Disorders (2024)
Open Access | Times Cited: 1
Luca Magistrelli, Marta Benedetta Brumana, Valeria Rimoldi, et al.
Movement Disorders (2024)
Open Access | Times Cited: 1